REGENERATE Trademark

Trademark Overview

On Wednesday, May 31, 2017, a trademark application was filed for REGENERATE with the United States Patent and Trademark Office. The USPTO has given the REGENERATE trademark a serial number of 87469943. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, July 27, 2017. This trademark is owned by Intercept Pharmaceuticals, Inc.. The REGENERATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of liver diseases and related diseases and disorders and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of liver diseases related diseases and disorders; Clinical research services, namely, collection, calibration, and reporting of data in connection with clinical trials of pharmaceuticals; reviewing standards and practices to assure compliance with federal food and drug laws and regulations; reviewing standards and practices and preparing reports relating to compliance with pharmaceutical drug safety laws and regulations; Providing medical and scientific research information in the field of clinical trials for liver diseases and other related disorders
regenerate

General Information

Serial Number87469943
Word MarkREGENERATE
Filing DateWednesday, May 31, 2017
Status601 - ABANDONED - EXPRESS
Status DateThursday, July 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the term REGENERATE with two lobes of a liver next to the letter R in REGENERATE.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials and studies for pharmaceutical preparations related to the treatment of liver diseases and related diseases and disorders and providing scientific information on the efficacy of pharmaceutical preparations for the treatment of liver diseases related diseases and disorders; Clinical research services, namely, collection, calibration, and reporting of data in connection with clinical trials of pharmaceuticals; reviewing standards and practices to assure compliance with federal food and drug laws and regulations; reviewing standards and practices and preparing reports relating to compliance with pharmaceutical drug safety laws and regulations; Providing medical and scientific research information in the field of clinical trials for liver diseases and other related disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Thursday, July 27, 2017ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Thursday, July 27, 2017ABANDONMENT - EXPRESS MAILED
Wednesday, July 26, 2017TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, July 25, 2017ASSIGNED TO EXAMINER
Thursday, June 8, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 3, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

regenerate diseases related clinical pharmaceutical liver trials disorders research scientific practices